Fire Dragon Pot Moxibustion
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05234814 |
Recruitment Status :
Completed
First Posted : February 10, 2022
Last Update Posted : February 10, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Insomnia Perimenopause | Other: Traditional Chinese Medicine auricular acupuncture point buried seeds therapy plus the fire dragon pot moxibustion therapy. Other: Traditional Chinese Medicine auricular acupuncture point buried seeds therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 70 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Participants with perimenopausal insomnia were randomly divided into a control group and an observation group. Participants in the control group were treated with the traditional Chinese medicine nursing intervention of burying seeds at auricular points. And participants in the observation group were additionally treated with fire dragon pot moxibustion. |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Clinical Study of Auricular Point Seed Burying Combined With Fire Dragon Pot Moxibustion in Perimenopausal Women With Insomnia |
Actual Study Start Date : | January 1, 2020 |
Actual Primary Completion Date : | October 30, 2020 |
Actual Study Completion Date : | October 30, 2020 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Control group
The control group was given the Traditional Chinese Medicine auricular acupuncture point buried seeds therapy.
|
Other: Traditional Chinese Medicine auricular acupuncture point buried seeds therapy
Ear acupuncture seed burial method According to "Ear Acupuncture Therapy" [6], the main acupuncture points were Shenmen, subcortical, sympathetic, endocrine, kidney, heart, liver and spleen (all acupuncture points were positioned according to the national standard: GB/T12346-2006). |
Experimental: Observation group
The observation group was given the auricular acupuncture point buried seeds therapy plus the fire dragon pot moxibustion therapy.
|
Other: Traditional Chinese Medicine auricular acupuncture point buried seeds therapy plus the fire dragon pot moxibustion therapy.
Fire dragon pot moxibustion treatment The main acupuncture points are as follows: Fengchi, Jianjin, Dazhui, Feiyu, Xinyu, Ganyu, Piyu, Shenyu, etc (all acupuncture points are positioned according to the national standard: GB/T12346-2006). Ear acupuncture seed burial method According to "Ear Acupuncture Therapy" [6], the main acupuncture points were Shenmen, subcortical, sympathetic, endocrine, kidney, heart, liver and spleen (all acupuncture points were positioned according to the national standard: GB/T12346-2006). |
- The score of Pittsburgh Sleepiness Quantifier Inventory [ Time Frame: one month ]The score of Pittsburgh Sleepiness Quantifier Inventory (PSQI) was compared between the two groups of patients before and after the intervention (For details, please refer to the literature: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research). A PSQI score <7 is considered good sleep quantity and ≥7 is poor sleep quality, and the higher the patient score, the worse the sleep quality.
- Adverse reactions [ Time Frame: one month ]Observe whether erythema, blisters, allergic and other adverse reactions are appearing

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All participants met the diagnosis of perimenopausal insomnia as described in the Chinese Guidelines for the Diagnosis and Treatment of Adult Insomnia (2017 Edition).
- Pittsburgh Sleep Quality Index (PSQI) >7.
- Insomnia at least 3 times per week and lasting for more than 1 month.
- Onset around menopause with menstrual disorders.
- No contraindications to auricular seed burial and fire dragon pot moxibustion treatment
- Informed consent.
Exclusion Criteria:
- Those with a duration of less than 1 week or those who have received other relevant treatment within the last month that affects the observation of efficacy
- Secondary insomnia due to physical illness or psychological disorders.
- Participants with severe co-morbidities and psychiatric disorders.
- Those who refuse to cooperate with treatment.
- Those who use other methods of treatment during the treatment period, which affects the judgment of efficacy.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05234814
China, Anhui | |
The Third Affiliated Hospital of Anhui Medical University (The first people ' s Hospital of Hefei) | |
Hefei, Anhui, China |
Principal Investigator: | Weihua Yu, Dr. | The Third Affiliated Hospital of Anhui Medical University |
Responsible Party: | Weihua Yu, Director of nursing department, Anhui Medical University |
ClinicalTrials.gov Identifier: | NCT05234814 |
Other Study ID Numbers: |
2019-041-01 |
First Posted: | February 10, 2022 Key Record Dates |
Last Update Posted: | February 10, 2022 |
Last Verified: | February 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | The data is available upon reasonable request |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Sleep Initiation and Maintenance Disorders Sleep Disorders, Intrinsic Dyssomnias |
Sleep Wake Disorders Nervous System Diseases Mental Disorders |